About
Technology stack
detected 2026-06-12No comments yet. Be the first to share your take.
What does Sylentis do?
Sylentis is a biopharmaceutical company specializing in ocular gene silencing therapies using RNA interference (RNAi) technology. They develop siRNA compounds to reduce the production of disease-causing proteins, with a current focus on treating dry eye syndrome and age-related macular degeneration. Sylentis also offers siRNA development services and collaborates with other companies on oligonucleotide-based drug development.
How much funding has Sylentis raised?
Sylentis has raised a total of $135M in funding. The most recent round on record is Series C.
Where is Sylentis headquartered?
Sylentis is headquartered in Madrid, Spain.
When was Sylentis founded?
Sylentis was founded in 2000.
What industry does Sylentis operate in?
Sylentis operates in Biotech, MedTech, HealthTech, Drug Discovery, Clinical Trials, Ophthalmology.
How many employees does Sylentis have?
Sylentis has approximately 61 people on record.